Browsing: ER2positivenegative
Imlunestrant, an investigational next-generation selective estrogen receptor antagonist (SERD), improved progression-free survival in patients with advanced endocrine therapy, ER-positive, HER2-negative…
Imlunestrant, an investigational next-generation selective estrogen receptor antagonist (SERD), improved progression-free survival in patients with advanced endocrine therapy, ER-positive, HER2-negative…